Oklahoma TSET Phase 1 Program

The Oklahoma TSET Phase I Program at the Stephenson Cancer Center provides an opportunity for cancer patients to participate in “first-in-human” clinical trials to access new and promising investigational agents.

The Oklahoma TSET Phase I Program is ranked among the top 10 Phase I programs in the nation for number of patients participating. It is the only Phase I Program in Oklahoma and surrounding region. To date, the Oklahoma TSET Phase I Program has conducted more than 225 early-phase clinical trials, with more than 1,250 patients participating.

Launched in partnership with Sarah Cannon Research Institute in Nashville, TN, the nation’s largest oncology Phase I center, the Oklahoma TSET Phase I Program is advancing the Stephenson Cancer Center’s mission of improving patient outcomes and raising the standard of cancer care of all Oklahomans.

The Stephenson’s Phase I Program is named in recognition of funding support provided by the Oklahoma Tobacco Settlement Endowment Trust (TSET).

Patient Information for Phase I Clinical Trials

If you or a loved one are seeking information on Phase I clinical trials at OU Health Stephenson Cancer Center, learn more by visiting our Phase I Clinical Trials page.

Patient Information for Phase I Clinical Trials
man and girl painting a wall
Explore Supportive Care services for your cancer journey Learn More
diabetes
Find out if you’re at risk for diabetes Learn More
See what our commitment to ending diabetes in this century means for you Learn More
Upcoming Events